milbemycin A3

(2aE,4E,5'S,6R,6'R,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,6',8,19-pentamethyl-3',4',5',6,6',7,10,11,14,15,17a,20,20a,20b-tetradecahydro-2H,17H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-17-one

ZLBGSRMUSVULIE-GSMJGMFJSA-N CHEBI:39228 0 Reactome links 2 studies

2 Observed studies

2 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: ZLBGSRMUSVULIE-GSMJGMFJSA-N
InChI Key: ZLBGSRMUSVULIE-GSMJGMFJSA-N
IUPAC name: (2aE,4E,5'S,6R,6'R,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,6',8,19-pentamethyl-3',4',5',6,6',7,10,11,14,15,17a,20,20a,20b-tetradecahydro-2H,17H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-17-one
Preferred name: milbemycin A3
INN name: —
Synonym: milbemycin A₃
ChEBI: CHEBI:39228

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles